Iniparib
Cat. No.：YN250297
CAS No. ：160003-66-7
| 产品名称: | Iniparib |
| CAS No.: | 160003-66-7 |
| Chemical Name: | 4-iodo-3-nitro-benzamide |
| Synonyms: | BSI-201; NSC-746045; IND-71677 |
| 分子量: | 292.03 |
| 分子式: | C₇H₅IN₂O₃ |
| SMILES: | O=C(C1=CC=C(C([N+]([O-])=O)=C1)I)N |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Iniparib (BSI-201) 是一种不可逆的PARP1抑制剂，可用于三阴性乳腺癌的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Yuan, Y., Liao, Y.M., Hsueh, C.T., et al.Novel targeted therapeutics: Inhibitors of MDM2, ALK and PARPJ. Hematol. Oncol.4(16),1-14(2011)
Javle, M., and Curtin, N.J.The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapyTher. Adv. Med. Oncol.3(6),257-267(2011)
Plummer, R.Poly(ADP-ribose) polymerase inhibition: A new direction for BRCA and triple-negative breast cancer?Breast Cancer Res.13(4),1-6(2011)
Bauer, P.I., Mendeleyeva, J., Kirsten, E., et al.Anti-cancer action of 4-iodo-3-nitrobenzamide in combination with buthionine sulfoximine: Inactivation of poly(ADP-ribose) polymerase and tumor glycolysis and the appearance of a poly(ADP-ribose) polymerase proteaseBiochem. Pharmacol.63,455-462(2002)
Mendeleyev, J., Kirsten, E., Hakam, A., et al.Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamideBiochem. Pharmacol.50(5),705-714(1995)
O'Shaughnessy, J., Osborne, C., Pippen, J.E., et al.Iniparib plus chemotherapy in metastatic triple-negative breast cancerN. Engl. J. Med.364(3),205-214(2011)
